# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001069530-23-000017
Filing Date
2023-05-01
Accepted
2023-05-01 09:25:13
Documents
61
Period of Report
2023-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | sava-20230331x10q.htm iXBRL | 10-Q | 1745665
2 | EX-31.1 | sava-20230331xex31_1.htm | EX-31.1 | 25544
3 | EX-31.2 | sava-20230331xex31_2.htm | EX-31.2 | 25243
4 | EX-32.1 | sava-20230331xex32_1.htm | EX-32.1 | 20220
5 | GRAPHIC | sava-20230331x10qg001.jpg | GRAPHIC | 62088
6 | GRAPHIC | sava-20230331x10qg002.jpg | GRAPHIC | 77567
7 | GRAPHIC | sava-20230331x10qg003.jpg | GRAPHIC | 93477
| Complete submission text file | 0001069530-23-000017.txt |  | 6297367

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | EX-101.SCH | sava-20230331.xsd | EX-101.SCH | 31192
9 | EX-101.CAL | sava-20230331_cal.xml | EX-101.CAL | 34839
10 | EX-101.DEF | sava-20230331_def.xml | EX-101.DEF | 104132
11 | EX-101.LAB | sava-20230331_lab.xml | EX-101.LAB | 250111
12 | EX-101.PRE | sava-20230331_pre.xml | EX-101.PRE | 222761
55 | EXTRACTED XBRL INSTANCE DOCUMENT | sava-20230331x10q_htm.xml | XML | 992874

Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29959 | Film No.: 23870623
SIC: 2834 Pharmaceutical Preparations